Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT00190502
Eligibility Criteria:
Inclusion Criteria:
* Type 1 diabetes
* Body mass index up to 32 kg/m2
* Exclusion of gravidity in women
* Known diagnosis of diabetes of less than 6 weeks
* Insulin dose of up to 40 IU per day for no longer than 1 month
* Positive for at least one autoantibody (GAD, IA2, ICA)
* C-peptide level ≥ 0.3 pmol/ml 4 min. following intravenous (IV) administration of 1 ml glucagon
* No concurrent severe infection
* Granulocyte count ≥ 2 x 10\^9/l
* Platelet count ≥ 120 x 10\^9/l
Exclusion Criteria:
* Other non-diabetes related autoimmune disease
* Previous immunosuppressive therapy
* Any clinical impairment precluding immunosuppressive therapy
* Leucopenia or thrombocytopenia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
35 Years
Study:
NCT00190502
Study Brief:
Protocol Section:
NCT00190502